Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Jun-16 4:26 PM View:  | McCoy John A. SVP and Controller | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 24,909 | -- | -- | (100%) 24.91K to 0 | |
| 07-Jun-16 4:26 PM View: | Ferrante Karen Jean Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 7,657 | -- | -- | (100%) 7.66K to 0 | |
| 07-Jun-16 4:27 PM View: | Nader Francois Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 7,657 | -- | -- | (100%) 7.66K to 0 | |
| 07-Jun-16 4:33 PM View: | Glasspool John See Remarks | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 1,461 | -- | -- | 4% 39.64K to 41.1K | |
| 07-Jun-16 4:29 PM View: | Forsyth John D Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 27,827 | -- | -- | (100%) 27.83K to 0 | |
| 07-Jun-16 4:31 PM View: | Edwards Peter G SVP AND GENERAL COUNSEL | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 216,343 | -- | -- | (100%) 216.34K to 0 | |
| 07-Jun-16 4:27 PM View: | Law Anne-Marie EVP & Head of Human Resources | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 85,262 | -- | -- | (100%) 85.26K to 0 | |
| 07-Jun-16 4:29 PM View: | Hantson Ludwig President and CEO Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 435,102 | -- | -- | (100%) 435.1K to 0 | |
| 07-Jun-16 4:34 PM View: | Hombach Robert J. EVP. CFO and COO | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 209,089 | -- | -- | (100%) 209.09K to 0 | |
| 07-Jun-16 4:33 PM View: | Leonardi Jacopo EVP and President, Immunology | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 1,095 | -- | -- | (100%) 1.09K to 0 | |
| 07-Jun-16 4:37 PM View: | Goff Brian EVP and President, Hematology | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 70,047 | -- | -- | (100%) 70.05K to 0 | |
| 07-Jun-16 4:28 PM View: | Hockmeyer Wayne T Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 19,039 | -- | -- | (100%) 19.04K to 0 | |
| 07-Jun-16 4:27 PM View: | Gavin James R III Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 30,747 | -- | -- | (100%) 30.75K to 0 | |
| 07-Jun-16 4:29 PM View: | Meek David D. EVP and President, Oncology | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 51,640 | -- | -- | (100%) 51.64K to 0 | |
| 07-Jun-16 4:33 PM View: | Glasspool John See Remarks | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 41,099 | -- | -- | (100%) 41.1K to 0 | |
| 07-Jun-16 4:30 PM View: | Orloff John J See Remarks | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 96,384 | -- | -- | (100%) 96.38K to 0 | |
| 07-Jun-16 4:32 PM View: | Stroucken Albert P L Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 22,194 | -- | -- | (97%) 22.89K to 0.7K | |
| 07-Jun-16 4:33 PM View: | Leonardi Jacopo EVP and President, Immunology | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 1,033 | -- | -- | 2% 56.43K to 57.46K | |
| 07-Jun-16 4:26 PM View: | McCoy John A. SVP and Controller | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 854 | -- | -- | 4% 24.05K to 24.91K | |
| 07-Jun-16 4:31 PM View: | Rosa-Bjorkeson Dagmar EVP and President, Biosimilars | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 71,293 | -- | -- | (100%) 71.29K to 0 | |
| 07-Jun-16 4:31 PM View: | Fosler Gail D Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 39,364 | -- | -- | (100%) 39.36K to 0 | |
| 07-Jun-16 4:24 PM View: | Devitt Blake E Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 32,857 | -- | -- | (100%) 32.86K to 0 | |
| 07-Jun-16 4:29 PM View: | Hantson Ludwig President and CEO Director | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 16,356 | -- | -- | 4% 418.75K to 435.1K | |
| 07-Jun-16 4:27 PM View: | Zagame Patrice See Remarks | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 88,942 | -- | -- | (100%) 88.94K to 0 | |
| 07-Jun-16 4:34 PM View: | Hombach Robert J. EVP. CFO and COO | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 16,356 | -- | -- | 8% 192.73K to 209.09K | |
| 07-Jun-16 4:32 PM View: | Stroucken Albert P L Director | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 696 | -- | -- | (100%) 0.7K to 0 | |
| 07-Jun-16 4:33 PM View: | Leonardi Jacopo EVP and President, Immunology | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 56,364 | -- | -- | (98%) 57.46K to 1.09K | |
| 07-Jun-16 4:37 PM View: | Goff Brian EVP and President, Hematology | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 2,881 | -- | -- | 4% 67.17K to 70.05K | |
| 26-May-16 6:55 PM View: | Devitt Blake E Director | Baxalta Inc (BXLT) | 24-May-16 | Purchase | 387 | -- | -- | 1% 32.47K to 32.86K | |
| 12-May-16 6:33 PM View: | Hockmeyer Wayne T Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 31% 14.54K to 19.04K | |
| 12-May-16 6:30 PM View: | Gavin James R III Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 17% 26.25K to 30.75K | |
| 12-May-16 6:28 PM View: | Stroucken Albert P L Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 24% 18.39K to 22.89K | |
| 12-May-16 6:46 PM View: | Fosler Gail D Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 13% 34.86K to 39.36K | |
| 12-May-16 6:30 PM View: | Devitt Blake E Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 16% 27.97K to 32.47K | |
| 12-May-16 6:44 PM View: | Ferrante Karen Jean Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 143% 3.16K to 7.66K | |
| 12-May-16 6:32 PM View: | Nader Francois Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 143% 3.16K to 7.66K | |
| 12-May-16 6:31 PM View: | Forsyth John D Director | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 19% 23.33K to 27.83K | |
| 28-Mar-16 4:31 PM View: | Gavin James R III Director | Baxalta Inc (BXLT) | 24-Mar-16 | Option Exercise | 5,660 | $17.97 | $101,710.00 | 21% 26.34K to 32.0K | |
| 28-Mar-16 4:33 PM View: | Forsyth John D Director | Baxalta Inc (BXLT) | 24-Mar-16 | Market Option Sale (Planned) | 5,660 | $39.97 | $226,230.00 | (20%) 28.98K to 23.32K | (16%) |
| 28-Mar-16 4:32 PM View: | Stroucken Albert P L Director | Baxalta Inc (BXLT) | 24-Mar-16 | Market Option Sale (Planned) | 5,660 | $39.98 | $226,287.00 | (21%) 26.41K to 20.75K | (16%) |
| 28-Mar-16 4:31 PM View: | Gavin James R III Director | Baxalta Inc (BXLT) | 24-Mar-16 | Market Option Sale (Planned) | 5,660 | $39.97 | $226,230.00 | (18%) 32.0K to 26.34K | (16%) |
| 28-Mar-16 4:33 PM View: | Forsyth John D Director | Baxalta Inc (BXLT) | 24-Mar-16 | Option Exercise | 5,660 | $17.97 | $101,710.00 | 24% 23.32K to 28.98K | |
| 28-Mar-16 4:32 PM View: | Stroucken Albert P L Director | Baxalta Inc (BXLT) | 24-Mar-16 | Option Exercise | 5,660 | $17.96 | $101,654.00 | 27% 20.75K to 26.41K | |
| 23-Mar-16 4:52 PM View: | Baxter International Inc 10% Owner | Baxalta Inc (BXLT) | 21-Mar-16 | Disposition (other) | 63,823,600 | -- | -- | (68%) 94.33M to 30.51M | |
| 08-Mar-16 4:58 PM View: | Leonardi Jacopo EVP and President, Immunology | Baxalta Inc (BXLT) | 07-Mar-16 | Payment of Exercise | 87 | $39.74 | $3,457.38 | (< 1%) 56.22K to 56.13K | (16%) |
| 08-Mar-16 4:57 PM View: | Glasspool John See Remarks | Baxalta Inc (BXLT) | 07-Mar-16 | Payment of Exercise | 154 | $39.74 | $6,119.96 | (< 1%) 39.59K to 39.44K | (16%) |
| 08-Mar-16 4:56 PM View: | McCoy John A. SVP and Controller | Baxalta Inc (BXLT) | 07-Mar-16 | Payment of Exercise | 84 | $39.74 | $3,338.16 | (< 1%) 24.11K to 24.03K | (16%) |
| 08-Mar-16 4:56 PM View: | Goff Brian EVP and President, Hematology | Baxalta Inc (BXLT) | 07-Mar-16 | Payment of Exercise | 267 | $39.74 | $10,610.60 | (< 1%) 67.3K to 67.03K | (16%) |
| 07-Mar-16 6:14 PM View: | McCoy John A. SVP and Controller | Baxalta Inc (BXLT) | 04-Mar-16 | Payment of Exercise | 88 | $39.47 | $3,473.36 | (< 1%) 24.2K to 24.11K | (17%) |
| 07-Mar-16 6:14 PM View: | Goff Brian EVP and President, Hematology | Baxalta Inc (BXLT) | 04-Mar-16 | Payment of Exercise | 303 | $39.47 | $11,959.40 | (< 1%) 67.6K to 67.3K | (17%) |
